SYNLAB International Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
23,000
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
18
- Investments
-
38
SYNLAB International General Information
Description
Provider of medical laboratory services catering to the needs of practising doctors, clinics and the pharmaceutical industry. The company offers a range of medical diagnostic services for patients, practising doctors, hospitals and clinics, governments and corporates.
Contact Information
Website
www.synlab.comCorporate Office
- Moosacher Straße 88
- 80809 Munich
- Germany
Corporate Office
- Moosacher Straße 88
- 80809 Munich
- Germany
SYNLAB International Timeline
SYNLAB International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SYNLAB International Comparisons
Industry
Financing
Details
SYNLAB International Competitors (8)
One of SYNLAB International’s 8 competitors is Biogroup (Levallois-Perret), a Private Equity-Backed company based in Levallois-Perret, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biogroup (Levallois-Perret) | Private Equity-Backed | Levallois-Perret, France | ||||
| ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
| Affidea | Private Equity-Backed | The Hague, Netherlands | ||||
| Unilabs | Private Equity-Backed | Geneva, Switzerland | ||||
| InHealth Group | Corporation | High Wycombe, United Kingdom |
SYNLAB International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SYNLAB International Patents
SYNLAB International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3353541-A1 | Method for dosing volatile short-chain fatty acids | Inactive | 21-Sep-2015 | ||
| EP-3137911-B1 | Method for assaying fatty acids in erythrocytes | Active | 29-Apr-2014 | ||
| EP-3137901-B1 | Method for determining urinary organic acids | Active | 29-Apr-2014 | ||
| EP-3137911-A1 | Method for dosing erythrocyte fatty acids | Active | 29-Apr-2014 | ||
| EP-3137901-A1 | Method for dosing urinary organic acids | Active | 29-Apr-2014 | G01N33/5308 |
SYNLAB International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SYNLAB International Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SYNLAB International Investments & Acquisitions (38)
SYNLAB International’s most recent deal was a Buyout/LBO with Analisi Mediche Pavanello. The deal was made on 02-Oct-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Analisi Mediche Pavanello | 02-Oct-2025 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| WolfartKlinik | 01-Jun-2023 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Labaf | 13-Jan-2023 | Merger/Acquisition | Other Services (B2C Non-Financial) | ||
| Sistemas Genómicos | 04-Jan-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Laboratorio Médico Polanco | 02-Nov-2021 | Merger/Acquisition | Laboratory Services (Healthcare) |
SYNLAB International Exits (2)
SYNLAB International’s most recent exit was on 01-Nov-2017 from Veterinary Pathology Group. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Veterinary Pathology Group | 01-Nov-2017 | Completed |
|
||
| Synergy Health | 02-Sep-2016 | Buyout/LBO | Completed |
|
SYNLAB International Affiliates
Subsidiaries (14)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Synlab Foundation | Munich, Germany | 2021 | |
| Lextox | Cardiff, United Kingdom | 2011 | |
| GenoID | Budapest, Hungary | 2001 | |
| FutureLAB Holding | Vienna, Austria | 2000 | |
| Swiss BioAnalytics | Birsfelden, Switzerland | 1999 |
SYNLAB International FAQs
-
When was SYNLAB International founded?
SYNLAB International was founded in 1998.
-
Where is SYNLAB International headquartered?
SYNLAB International is headquartered in Munich, Germany.
-
What is the size of SYNLAB International?
SYNLAB International has 23,000 total employees.
-
What industry is SYNLAB International in?
SYNLAB International’s primary industry is Laboratory Services (Healthcare).
-
Is SYNLAB International a private or public company?
SYNLAB International is a Private company.
-
What is SYNLAB International’s current revenue?
The current revenue for SYNLAB International is .
-
How much funding has SYNLAB International raised over time?
SYNLAB International has raised $3.07B.
-
Who are SYNLAB International’s investors?
Labcorp Holdings and Cinven have invested in SYNLAB International.
-
Who are SYNLAB International’s competitors?
Biogroup (Levallois-Perret), ARUP Laboratories, Affidea, Unilabs, and InHealth Group are some of the 8 competitors of SYNLAB International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
